SLC2A1 and urinary bladder carcinoma: Figure 8F,G shows the single‐gene GSEA analysis of SLC2A1 and TXNIP, we observed that SLC2A1 is mainly concentrated in KEGG bladder cancer, cell cycle, pancreatic cancer, renal cell carcinoma, ubiquitin‐mediated proteolysis pathway, and it is upregulated.